All Stories

  1. In Silico Discovery of Tanshinone I, a Diterpenoid from Salvia miltiorrhiza (Danshen), as a Dual Antiviral Natural Inhibitor Targeting Conserved Allosteric Sites of HMPV and HRSV RNA-Dependent RNA Polymerases
  2. Discovery of natural compounds as novel FMS-like tyrosine kinase-3 (FLT3) therapeutic inhibitors for the treatment of acute myeloid leukemia: An in-silico approach
  3. Computational modeling and optimization of peptide-based CAR-T cell receptors targeting CD19 for enhanced efficacy and minimized toxicity
  4. Computational modeling and optimization of peptide-based CAR-T cell receptors targeting CD19 for enhanced efficacy and minimized toxicity
  5. In silico exploration natural compounds for the discovery of novel DNMT3A inhibitors as potential therapeutic agents for acute myeloid leukemia
  6. Quantum Enabled Protein Folding of Disordered Regions in Ubiquitin C Via Error Mitigated VQE Benchamrked on Tensor Network Simulator and Aria 1
  7. Targeting the G-quadruplex structure in the hTERT promoter for telomerase activity: in silico screening of phyto-compounds and long timescale replica exchange molecular dynamic simulations
  8. Advanced Strategies in Quantitative Structure Activity Relationship (QSAR) Modeling
  9. Computational Theories Shaping the Future of Drug Discovery
  10. In silicoExploration Natural Compounds for the Discovery of Novel DNMT3A Inhibitors as Potential Therapeutic Agents for Acute Myeloid Leukemia
  11. Discovery of natural compounds as novel FMS-like tyrosine kinase-3 (FLT3) therapeutic inhibitors for the treatment of acute myeloid leukemia: anin silicoapproach
  12. Computational Insights into Papaveroline as an In Silico Drug Candidate for Alzheimer’s Disease via Fyn Tyrosine Kinase Inhibition
  13. Quantum synergy in peptide folding: A comparative study of CVaR-variational quantum eigensolver and molecular dynamics simulation
  14. Disaggregation of amyloid-beta fibrils via natural metabolites using long timescale replica exchange molecular dynamics simulation studies
  15. A comparative insight into peptide folding with quantum CVaR-VQE algorithm, MD simulations and structural alphabet analysis
  16. Exploring the Role of Non-synonymous and Deleterious Variants Identified in Colorectal Cancer: A Multi-dimensional Computational Scrutiny of Exomes
  17. Targeting the G-quadruplex structure in the hTERT promoter: In silico screening of phytocompounds and replica exchange molecular dynamics simulations
  18. Deciphering the scope of in silico screening of novel natural lead molecules against putative molecular targets of multidrug-resistant bacterial pathogens
  19. Protocol for the development of coarse-grained structures for macromolecular simulation using GROMACS v2
  20. BRCA1/TP53 tumor proteins inhibited by novel analogues of curcumin — Insight from computational modelling, dynamic simulation and experimental validation
  21. A Comparative Analysis of Quantum Computing Variational Quantum Eigensolver Algorithm and Molecular Dynamics Simulations for Peptide Folding
  22. Design of Novel Imidazopyrazine Derivative against Breast Cancer via Targeted NPY1R Antagonist
  23. Protocol for the development of coarse-grained structures for macromolecular simulation using GROMACS
  24. De Novo Design of Anti-COVID Drugs Using Machine Learning-Based Equivariant Diffusion Model Targeting the Spike Protein
  25. Carboxymuconolactone decarboxylase is a prospective molecular target for multi-drug resistant Acinetobacter baumannii-computational modeling, molecular docking and dynamic simulation studies
  26. Insights on Novel Effectors and Characterization of Metacaspase (RS107_6) as a Potential Cell Death-Inducing Protein in Rhizoctonia solani
  27. Protocol for the development of coarse-grained structures for macromolecular simulation using GROMACS v1
  28. Transcription factors controlling the expression of oxidative stress associated genes in rice (Oryza sativa L.)
  29. High Throughput Ligand Interaction Profiler v1
  30. Computational design of prospective molecular targets for Burkholderia cepacia complex by molecular docking and dynamic simulation studies
  31. Design of Novel Coumarin Derivatives as NUDT5 Antagonists That Act by Restricting ATP Synthesis in Breast Cancer Cells
  32. Novel 1,2,5-Trisubstituted Benzimidazoles Potentiate Apoptosis by Mitochondrial Dysfunction in Panel of Cancer Cells
  33. A Machine Learning-Based Approach Using Multi-omics Data to Predict Metabolic Pathways
  34. Mycobacterium Time-Series Genome Analysis Identifies AAC2′ as a Potential Drug Target with Naloxone Showing Potential Bait Drug Synergism
  35. A Simple and Rapid Oxidative Stress Screening Method of Small Molecules for Functional Studies of Transcription Factor
  36. Correction to: Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2
  37. Brefeldin A variant via combinatorial screening acts as an effective antagonist inducing structural modification in EPAC2
  38. Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2
  39. Protocol for In-silico Design, Docking and Molecular Dynamic Simulation of Antisense Oligonucleotides v1
  40. Novel small molecules targeting bZIP23 TF improve stomatal conductance and photosynthesis under mild drought stress by regulating ABA
  41. Long Short Term Memory model for accurate predictions of Single Nucleotide Polymorphisms in Mycobacterium tuberculosis from timeseries genome analysis
  42. Molecular dynamics simulation and docking analysis of NF-κB protein binding with sulindac acid
  43. Well-tempered Metadynamics protocol v2
  44. Coumarin derivative as a potent drug candidate against triple negative breast cancer targeting the frizzled receptor of wingless-related integration site signaling pathway
  45. Carbon fullerene and nanotube are probable binders to multiple targets of SARS-CoV-2: Insights from computational modeling and molecular dynamic simulation studies
  46. Molecular Docking and Interaction Studies of Identified Abscisic Acid Receptors in Oryza sativa: An In-Silico Perspective on Comprehending Stress Tolerance Mechanisms
  47. Study of SARS-nCoV2 Indian Isolates Gaining Insights into Mutation Frequencies, Protein Stability and Prospective Effect on Pathogenicity
  48. Understanding the Xylooligosaccharides Utilization Mechanism of Lactobacillus brevis and Bifidobacterium adolescentis: Proteins Involved and Their Conformational Stabilities for Effectual Binding
  49. Molecular dynamics simulation and docking studies reveal NF-κB as a promising therapeutic drug target for COVID-19
  50. Structural insights on the interaction potential of natural leads against major protein targets of SARS-CoV-2: Molecular modelling, docking and dynamic simulation studies
  51. Re-profiling of natural inhibitor via combinatorial drug screening: Brefeldin A variant design as an effective antagonist leading to EPAC2 structure modification and antibody design for identification
  52. Spiro Benzodiazepine Substituted Fluorocoumarins as Potent Anti-Anxiety Agents
  53. Stress-Induced Detoxification Enzymes in Rice Have Broad Substrate Affinity
  54. Structural and molecular basis of the interaction mechanism of selected drugs towards multiple targets of SARS-CoV-2 by molecular docking and dynamic simulation studies- deciphering the scope of repurposed drugs
  55. Response regulator GacA and transcriptional activator RhlR proteins involved in biofilm formation of Pseudomonas aeruginosa are prospective targets for natural lead molecules: Computational modelling, molecular docking and dynamic simulation studies
  56. Natural epiestriol-16 act as potential lead molecule against prospective molecular targets of multidrug resistant Acinetobacter baumannii-Insight from in silico modelling and in vitro investigations
  57. Carbon fullerene acts as potential lead molecule against prospective molecular targets of biofilm-producing multidrug-resistant Acinetobacter baumanni and Pseudomonas aerugenosa: computational modeling and MD simulation studies
  58. Mitogen activated protein kinase-1 and cell division control protein-42 are putative targets for the binding of novel natural lead molecules: a therapeutic intervention against Candida albicans
  59. Genome Resequencing Reveals Single Nucleotide Polymorphism and Repeat Regions in Giardia lamblia Indian Isolate